Location Cambridge, Cambridgeshire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
John is an Oncology Bioinformatics consultant with a PhD is cancer genetics. Previously he lead Oncology Research Bioinformatics at MedImmune, the biologics arm of AstraZeneca (AZ) where his research activities concentrated on supporting preclinical antibody drug conjugate (ADC) and Immuno-oncology drug development projects. John focused on the
‘omic characterisation of tumour model systems, including syngeneic mice, along with the analysis of patient data to deliver predictive signatures, markers and disease line of sight; along with informatics strategy development.
Prior to Medimmune John was head of Biomics at KuDOS pharmaceuticals (which became the AZ Oncology DNA damage repair (DDR) inhibitor group). He provided support on target selection, network analysis of the DDR pathways and headed a team delivering key biomarker results to support DNA repair inhibitor drug projects including Lynparza.
